Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology.

Journal: International journal of molecular sciences
PMID:

Abstract

Reverse vaccinology (RV) is a bioinformatics approach that can predict antigens with protective potential from the protein coding genomes of bacterial pathogens for subunit vaccine design. RV has become firmly established following the development of the BEXSERO® vaccine against Neisseria meningitidis serogroup B. RV studies have begun to incorporate machine learning (ML) techniques to distinguish bacterial protective antigens (BPAs) from non-BPAs. This research contributes significantly to the RV field by using permutation analysis to demonstrate that a signal for protective antigens can be curated from published data. Furthermore, the effects of the following on an ML approach to RV were also assessed: nested cross-validation, balancing selection of non-BPAs for subcellular localization, increasing the training data, and incorporating greater numbers of protein annotation tools for feature generation. These enhancements yielded a support vector machine (SVM) classifier that could discriminate BPAs (n = 200) from non-BPAs (n = 200) with an area under the curve (AUC) of 0.787. In addition, hierarchical clustering of BPAs revealed that intracellular BPAs clustered separately from extracellular BPAs. However, no immediate benefit was derived when training SVM classifiers on data sets exclusively containing intra- or extracellular BPAs. In conclusion, this work demonstrates that ML classifiers have great utility in RV approaches and will lead to new subunit vaccines in the future.

Authors

  • Ashley I Heinson
    Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK. a.heinson@soton.ac.uk.
  • Yawwani Gunawardana
    Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK. y.p.gunawardana@soton.ac.uk.
  • Bastiaan Moesker
    Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK. bastiaanmoesker@gmail.com.
  • Carmen C Denman Hume
    London School of Hygiene and Tropical Medicine (LSHTM), Department of Pathogen Molecular BiologyLondon WC1E 7HT, UK. carmen.denman@gmail.com.
  • Elena Vataga
    Solutions, University of Southampton, Southampton SO17 1BJ, UK. e.vataga@soton.ac.uk.
  • Yper Hall
    Public Health England, National Infection Service, Porton Down Salisbury, SP4 0JG, UK. yper.hall@phe.gov.uk.
  • Elena Stylianou
    The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK. elena.stylianou@ndm.ox.ac.uk.
  • Helen McShane
  • Ann Williams
    Public Health England, National Infection Service, Porton Down Salisbury, SP4 0JG, UK. ann.rawkins@phe.gov.uk.
  • Mahesan Niranjan
    Department of Electronics and Computer Science, University of Southampton, Southampton SO17 1BJ, UK. mn@ecs.soton.ac.uk.
  • Christopher H Woelk
    Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK. c.h.woelk@soton.ac.uk.